News Releases Year: All News20182017201620152014201320122011 Items per page All News2550 March 27, 2018 Summary ToggleAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Read more March 7, 2018 Summary ToggleAllena Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference Read more March 6, 2018 Summary ToggleAllena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria Read more December 14, 2017 Summary ToggleAllena Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update Read more November 1, 2017 Summary ToggleAllena Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering Read more July 27, 2017 Summary ToggleEuropean Commission Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria Read more July 13, 2017 Summary ToggleFDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria Read more May 31, 2017 Summary ToggleAllena Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Read more March 3, 2017 Summary ToggleAllena Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference Read more January 5, 2017 Summary ToggleAllena Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference Read more Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next Last page Last
